Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1998-08-13
2000-12-12
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514546, 514912, A67K 3166, A67K 3122
Patent
active
061599581
ABSTRACT:
Compositions containing 2-(phosphonomethyl)-pentanedioic acid (PMPA) and pha. and .beta. N-acetyl-aspartyl-glutamate (NAAG) are appropriate means for treatment of neuronal tissue injury that may result from such factors as injury, toxicity, hypoxia or ischemia (a frequent cause of hypoxia). Target tissues include the brain, spinal cord and retina.
REFERENCES:
patent: 5597809 (1997-01-01), Dreyer
Hacker Henry D.
Long Joseph B.
Meyerhoff James M.
Arwine Elizabeth
Fay Zohreh
Harris Charles H.
The United States of America as represented by the Secretary of
LandOfFree
Treatment or prophylaxis of retinal pathology and spinal cord in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment or prophylaxis of retinal pathology and spinal cord in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment or prophylaxis of retinal pathology and spinal cord in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217244